Pharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifen

dc.article.end-page16en
dc.article.start-page1en
dc.citation.doi10.3390/JPM13020272en
dc.contributor.authorC R Kanjien
dc.contributor.authorG Nyabadzaen
dc.contributor.authorC Nhachien
dc.contributor.authorCollen Masimirembwaen
dc.date.accessioned2024-07-23T05:57:48Z
dc.date.available2024-07-23T05:57:48Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.urihttps://hdl.handle.net/10539/39331
dc.journal.titlePharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifenen
dc.journal.volume13en
dc.titlePharmacokinetics of Tamoxifen and Its Major Metabolites and the Effect of the African Ancestry Specific CYP2D617 Variant on the Formation of the Active Metabolite Endoxifenen
dc.typeJournal Articleen
Files